Skip header and navigation

Narrow By

   MORE

9 records – page 1 of 1.

5-Aminosalicylate (5-ASA) for inflammatory bowel disease (IBD)

https://libcat.nshealth.ca/en/permalink/chpams35397
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1483
Available Online
View Pamphlet
5-aminosalicylate (5-ASA) is a medication often used to treat inflammatory bowel disease (IBD). It helps to controll active ulcerative colitis, or Crohn’s colitis and keep mild to moderate ulcerative colitis in remission (period of recovery). Topics include: what does 5-ASA do, which 5-ASA you should take, how to take 5-ASA, what other medications you can take, and how 5-ASA will help. The pamphlet also describes side effects and how long you will need to take 5-ASA.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Inflammatory Bowel Diseases - drug therapy
Crohn Disease - drug therapy
Colitis - drug therapy
Subjects (LCSH)
Inflammatory bowel diseases
Crohn's disease
Colitis
Abstract
5-aminosalicylate (5-ASA) is a medication often used to treat inflammatory bowel disease (IBD). It helps to controll active ulcerative colitis, or Crohn’s colitis and keep mild to moderate ulcerative colitis in remission (period of recovery). Topics include: what does 5-ASA do, which 5-ASA you should take, how to take 5-ASA, what other medications you can take, and how 5-ASA will help. The pamphlet also describes side effects and how long you will need to take 5-ASA.
Notes
Previous title: 5-Aminosalicylate (5-ASA)
Responsibility
Prepared by: Nova Scotia Collaborative IBD Program
Pamphlet Number
1483
Less detail

Atlas of endoscopy imaging in inflammatory bowel disease

https://libcat.nshealth.ca/en/permalink/provcat50375
Shen, Bo. --London, England: Academic Press , 2020.
Available Online
View e-Book
Location
Online
Available Online
View e-Book
Author
Shen, Bo
Place of Publication
London, England
Publisher
Academic Press
Date of Publication
2020
ISBN
9780128148112
Subjects (MeSH)
Endoscopy, Gastrointestinal
Inflammatory Bowel Diseases
Notes
Access to this online resource is restricted to IWK Health Centre employees working from inside the hospital network.
Format
e-Book
Publication Type
Atlas
Location
Online
Less detail

Colitis-Associated Cancer

https://libcat.nshealth.ca/en/permalink/provcat40391
Masato Kusunoki, editor. (1st ed.) --Tokyo: Springer Japan , c2016.
Available Online
View e-Book
Location
Online
As the number of patients with colitis-associated cancer (CAC) is on the increase, the purpose of this book is to review the latest topics concerning management of the disease. In recent years, the diagnostic power of endoscopy and molecular pathology has also grown tremendously, as a result of which they now have a far greater influence on the treatment of CAC. At the moment, appropriate monitoring programs for ulcerative colitis and Crohn's disease remain uncertain. At the same time, the late…
Available Online
View e-Book
Other Authors
Kusunoki, Masato
Responsibility
Masato Kusunoki, editor
Edition
1st ed.
Place of Publication
Tokyo
Publisher
Springer Japan
Date of Publication
c2016
Physical Description
1 online resource (viii, 150 p. : 21 illus., 15 illus. in color)
ISBN
9784431555223
9784431555216 (print ed.)
Subjects (MeSH)
Colitis - complications
Colonic Neoplasms - etiology
Inflammatory Bowel Diseases
Abstract
As the number of patients with colitis-associated cancer (CAC) is on the increase, the purpose of this book is to review the latest topics concerning management of the disease. In recent years, the diagnostic power of endoscopy and molecular pathology has also grown tremendously, as a result of which they now have a far greater influence on the treatment of CAC. At the moment, appropriate monitoring programs for ulcerative colitis and Crohn's disease remain uncertain. At the same time, the latest findings on DNA methylation and microRNAs hold the promise of making revolutionary changes in these areas. Moreover, recent drug advances in the treatment of inflammatory bowel diseases have changed surgical indications. On the other hand, the indication of mucosectomy on colorectal cancer in ulcerative colitis and prophylactic abdominoperineal resection for Crohn's disease remain controversial. This book provides the latest information on the remaining issues of CAC from the point of view of expert surgeons.
Contents
1. Colitis-Associated Cancer: Overview -- Part I. Clinical Features -- 2. Incidence and Risk Factors -- 3. Prevention and Prognosis -- Part II. Diagnosis -- 4. Cancer Surveillance of Patients with Long-Standing Inflammatory Bowel Disease -- 5. Molecular Alterations in Inflammatory Colonic Carcinogenesis and Markers for Detecting Colitis-Associated Cancer -- Part III. Surgical Treatment -- 6. Surgical Treatment for Ulcerative Colitis-Associated Cancer or Dysplasia -- 7. Surgical Treatment for Colorectal Cancer in Crohn's Disease.
Format
e-Book
Location
Online
Less detail

Inflammatory Bowel Disease : A Point of Care Clinical Guide

https://libcat.nshealth.ca/en/permalink/provcat39181
Daniel J. Stein, Reza Shaker, editors. --Cham: Springer , c2015.
Available Online
View e-Book
Location
Online
This volume provides a unique point-of-care reference for clinicians who care for Inflammatory Bowel Disease patients. Busy clinicians need the best evidence based answers to patient questions at their fingertips at the time questions present themselves. Each chapter is based on responses to common IBD patient questions from IBD experts who answer these questions every day. Through these questions this book guides clinicians through the complicated management of IBD; including disease onset and…
Available Online
View e-Book
Other Authors
Stein, Daniel J
Shaker, Reza
Responsibility
Daniel J. Stein, Reza Shaker, editors
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2015
Physical Description
1 online resource (xvii, 237 p. : 4 illus., 3 illus. in color)
ISBN
9783319140728
9783319140711 (print ed.)
Subjects (MeSH)
Inflammatory Bowel Diseases
Evidence-Based Medicine - methods
Abstract
This volume provides a unique point-of-care reference for clinicians who care for Inflammatory Bowel Disease patients. Busy clinicians need the best evidence based answers to patient questions at their fingertips at the time questions present themselves. Each chapter is based on responses to common IBD patient questions from IBD experts who answer these questions every day. Through these questions this book guides clinicians through the complicated management of IBD; including disease onset and natural history, therapy initiation, medications complications, therapeutic monitoring, surgery and accurate disease monitoring. Lastly, the book addresses special situations, such as alternative therapies, pregnancy, and fertility. Written by experts in the field, Inflammatory Bowel Disease: A Point of Care Clinical Guide is a valuable reference for gastroenterologists, gastroenterology fellows, mid-level providers and any clinician involved in the care of IBD patients.
Contents
[publisher supplied] 1. Why did this happen to me?: Epidemiology, Genetics, Environment, and Etiology of IBD -- 2. So what is Crohn's disease and Ulcerative colitis?: Making the proper diagnosis, avoiding IBD mimickers, and identifying factors that distinguish CD from UC -- 3. What happens if I do nothing?: The natural history of IBD, treated and untreated -- 4. Proper staging and management of newly diagnosed Crohn's disease -- 5. Proper staging and management of newly diagnosed Ulcerative colitis -- 6. Monitoring for common side effects and adverse reactions of IBD medications -- 7. Healthcare maintenance in patients with IBD -- 8. Pregnancy and unique women's issues in IBD -- 9. Imaging and IBD -- 10. Perianal Crohn's disease -- 11. Surgical management of Crohn's disease -- 12. Management of severe/fulminant Ulcerative colitis -- 13. Surgical management of Ulcerative colitis -- 14. Post operative management of IBD patients -- 15. Pouchitis -- 16. Ostomies.
Format
e-Book
Location
Online
Less detail

Inflammatory Bowel Disease : From Bench to Bedside

https://libcat.nshealth.ca/en/permalink/provcat40487
edited by Stephan R. Targan, Fergus Shanahan, Loren C. Karp. (2nd edition) --New York: Springer , c2003.
Available Online
View e-Book
Location
Online
Inflammatory Bowel Disease: From Bench to Bedside is a detailed and comprehensive story of the local and systemic pathophysiology of intestinal inflammation including management strategies. Research advances and current concepts of etiopathogenesis in the context of what is already known of the clinicopathologic features of these disorders are explored. This volume blends recent advances in the basic and clinical sciences as they relate to inflammatory bowel disease and emphasizes the effective…
Available Online
View e-Book
Other Authors
Targan, Stephan R
Shanahan, Fergus
Karp, Loren C
Responsibility
edited by Stephan R. Targan, Fergus Shanahan, Loren C. Karp
Edition
2nd edition
Place of Publication
New York
Publisher
Springer
Date of Publication
c2003
Physical Description
1 online resource (xvi, 903 p. : 98 illus., 9 illus. in color)
ISBN
9780387258089
9780387258072 (print ed.)
Subjects (MeSH)
Inflammatory Bowel Diseases
Abstract
Inflammatory Bowel Disease: From Bench to Bedside is a detailed and comprehensive story of the local and systemic pathophysiology of intestinal inflammation including management strategies. Research advances and current concepts of etiopathogenesis in the context of what is already known of the clinicopathologic features of these disorders are explored. This volume blends recent advances in the basic and clinical sciences as they relate to inflammatory bowel disease and emphasizes the effectiveness of a team approach of basic scientists and clinician investigators in this field.
Contents
Section 1. The laboratory bench -- 1. Introduction: Inflammatory bowel diseases: from bench to bedside -- 2. The changing faces of Crohn's disease and ulcerative colitis -- 3. Genetics of inflammatory bowel disease -- 4. Experimental mouse models of inflammatory bowel disease: new insights into pathogenic mechanisms -- 5. The normal intestinal mucosa: a state of 'controlled inflammation' -- 6. The lymphocyte-epithelial-bacterial interface -- 7. The mucosal inflammatory response. Cytokines and chemokines -- 8. Role of the microcirculation in chronic gut inflammation -- 9. Remission, relapse, intestinal healing and repair -- 10. Antibodies in the exploration of inflammatory bowel disease pathogenesis and disease stratification -- 11. Pathophysiology of inflammatory bowel disease: the effect of inflammation on intestinal function -- 12. Systemic consequences of intestinal inflammation -- Section II. The bedside -- 13. Understanding symptoms and signs in inflammatory bowel disease -- 14. Clinical course and complications of ulcerative colitis and ulcerative proctitis -- 15. Clinical features and complications of Crohn's disease -- 16. Mechanisms of systemic inflammation associated with intestinal injury -- 17. Pathology of inflammatory bowel diseases: a critical appraisal in diagnosis and management -- 18. An endoscopic and histologic perspective of diagnosis: when, where, and what to do -- 19. Radiologic (radiographic) and imaging features of ulcerative cohtis and Crohn's disease -- 20. New diagnostic approaches in inflammatory bowel disease -- 21. Differential diagnosis of colitis -- 22. 'Disease management' in chronic medical conditions -- 23. Pharmacoeconomics and inflammatory bowel disease -- 24. Measuring quality of life in inflammatory bowel disease -- 25. Clinical pharmacology in inflammatory bowel disease: optimizing current medical therapy -- 26. Multi-site therapeutic modalities for inflammatory bowel diseases - mechanisms of action -- 27. Targeted therapies for inflammatory bowel disease -- 28. Role of antibiotics and probiotics in the management of inflammatory bowel disease -- 29. Nutrition in inflammatory bowel disease -- 30. Medical management of ulcerative colitis -- 31. Surgical management of ulcerative colitis -- 32. Pouchitis: clinical characteristics and management -- 33. Medical therapy for Crohn's disease -- 34. Surgery for Crohn's disease -- 35. Postoperative prevention of recurrence of Crohn's disease -- 36. The molecular pathology of inflammatory bowel disease-associated neoplasia and preneoplasia -- 37. Dysplasia in inflammatory bowel disease: clinical pathology and current surveillance methods -- 38. Hepatobiliary disorders -- 39. Articular and ocular complications of inflammatory bowel disease -- 40. Cutaneous manifestations of inflammatory bowel disease -- 41. Fertility and pregnancy in inflammatory bowel disease -- 42. Special considerations in the diagnosis and management of inflammatory bowel disease in the pediatric age group -- 43. Microscopic colitis: collagenous and lymphocytic colitis -- 44. Colon ischemia -- 45. Diversion colitis -- 46. Pseudomembranous colitis and Clostridium difficile infection -- 47. Infectious colitis -- 48. Human immunodeficiency virus and inflammatory bowel disease -- 49. Bone metabolism and inflammatory bowel disease -- Section III. Back to the laboratory bench -- 50. Epilogue: Bench to bedside and back to bench.
Format
e-Book
Location
Online
Less detail

Interventional inflammatory bowel diseases : endoscopic management and treatment of complications

https://libcat.nshealth.ca/en/permalink/provcat42077
edited by Bo Shen. (1st ed.) --London, UK: Elsevier , c2018.
Available Online
View e-Book
Access
Registration required for PDF access.
Location
Online
Interventional Inflammatory Bowel Diseases: Endoscopic Management and Treatment of Complications covers the preparation, principle, techniques, and damage control of complications in endoscopic therapy providing the ultimate guidance in endoscopic management of IBD. With contributions from a panel of international leading experts in the field, perspectives are included from GI pathologists, GI radiologists, gastroenterologists, advanced endoscopists, IBD specialists, and colorectal surgeons.
Available Online
View e-Book
Other Authors
Shen, Bo
Responsibility
edited by Bo Shen
Edition
1st ed.
Alternate Title
Atlas of surgical techniques for the upper GI tract and small bowel
Place of Publication
London, UK
Publisher
Elsevier
Date of Publication
c2018
Physical Description
1 online resource, 352 p.
ISBN
9780128113882
Subjects (MeSH)
Inflammatory Bowel Diseases
Specialty
Endoscopy
Gastroenterology
Abstract
Interventional Inflammatory Bowel Diseases: Endoscopic Management and Treatment of Complications covers the preparation, principle, techniques, and damage control of complications in endoscopic therapy providing the ultimate guidance in endoscopic management of IBD. With contributions from a panel of international leading experts in the field, perspectives are included from GI pathologists, GI radiologists, gastroenterologists, advanced endoscopists, IBD specialists, and colorectal surgeons.
Access
Registration required for PDF access.
Format
e-Book
Location
Online
Less detail

Methotrexate (MTX) therapy for inflammatory bowel disease (IBD)

https://libcat.nshealth.ca/en/permalink/chpams34942
Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1138
Available Online
View Pamphlet
Your health care provider feels that treatment with methotrexate (meth-oh-TREX-ate) might help your Crohn’s disease or ulcerative colitis. These are both types of inflammatory bowel disease (IBD). This pamphlet explains what methotrexate (MTX) is, how well it works, side effects of MTX, who should not take MTX, and precautions. Instructions for injecting MTX are given.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document (13 p.) : digital, PDF file
Subjects (MeSH)
Methotrexate
Crohn's disease
Inflammatory Bowel Diseases
Immunosuppressive Agents
Subjects (LCSH)
Crohn's disease
Methotrexate
Immunosuppressive agents
Inflammatory bowel diseases
Specialty
Gastrointestinal System
Medications
Abstract
Your health care provider feels that treatment with methotrexate (meth-oh-TREX-ate) might help your Crohn’s disease or ulcerative colitis. These are both types of inflammatory bowel disease (IBD). This pamphlet explains what methotrexate (MTX) is, how well it works, side effects of MTX, who should not take MTX, and precautions. Instructions for injecting MTX are given.
Responsibility
Prepared by: Nova Scotia Collaborative Inflammatory Bowel Disease Program
Pamphlet Number
1138
Less detail

Telemanagement of Inflammatory Bowel Disease

https://libcat.nshealth.ca/en/permalink/provcat39871
Raymond K. Cross, Andrew R. Watson, editors. (1st ed.) --Cham: Springer , c2016.
Available Online
View e-Book
Location
Online
This volume provides a comprehensive, state-of-the art review of inflammatory bowel disease and its management through the use of telemedicine applications. The book reviews barriers to successful outcomes in patients with IBD and offers a rationale for how self-management and telemedicine approaches can improve care in chronic illnesses such as IBD. This volume also includes a summary of the burden of telephone encounters in patients with IBD, characteristics of frequent callers to the office,…
Available Online
View e-Book
Other Authors
Cross, Raymond K
Watson, Andrew R
Responsibility
Raymond K. Cross, Andrew R. Watson, editors
Edition
1st ed.
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2016
Physical Description
1 online resource (xii, 194 p. : 31 illus., 23 illus. in color)
ISBN
9783319222851
9783319222844 (print ed.)
Subjects (MeSH)
Inflammatory Bowel Diseases
Telemedicine - methods
Treatment Outcome
Abstract
This volume provides a comprehensive, state-of-the art review of inflammatory bowel disease and its management through the use of telemedicine applications. The book reviews barriers to successful outcomes in patients with IBD and offers a rationale for how self-management and telemedicine approaches can improve care in chronic illnesses such as IBD. This volume also includes a summary of the burden of telephone encounters in patients with IBD, characteristics of frequent callers to the office, outcomes associated with high telephone use, and strategies to provide education via telephone to patients with IBD. Prior literature on implementation of teleconsultation in research and clinical practice, as well as mobile applications used to track symptoms, quality of life, diet, and medication use in IBD are also explored in the book. Written by experts in the field, Telemanagement of Inflammatory Bowel Disease is a valuable resource for gastroenterologists, surgeons, and other clinicians dealing with, and interested in, this novel adjunct to routine care for inflammatory bowel disease.
Contents
1. Barriers to Successful Outcomes in Patients with Inflammatory Bowel Diseases -- 2. Experience with Telemedicine Systems in Chronic Illness: What Can We Learn -- 3. Telephone Encounters in Inflammatory Bowel Disease (IBD) Care: Burden, Risk Factors, and Opportunities for Intervention -- 4. Teleconsultation in the Care of Patients with IBD -- 5. Self-Management Techniques in IBD -- 6. Mobile Applications for Patients with Inflammatory Bowel Disease -- 7. Telemonitoring and Self-Care in Patients with IBD -- 8. Teleconferences to Facilitate Multidisciplinary Care and Education in IBD -- 9. System Requirements for Delivery of Telemedicine Services -- 10. Legal, Regulatory, and Ethical Issues in the Use of Telemedicine -- 11. Future Directions in Telemedicine Applications for Inflammatory Bowel Disease (IBD).
Format
e-Book
Location
Online
Less detail

Ulcerative proctitis

https://libcat.nshealth.ca/en/permalink/chpams35311
Nova Scotia Health Authority. GI Clinic. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1422
Available Online
View Pamphlet
Ulcerative proctitis is a type of inflammatory bowel disease. Inflammatory bowel disease (IBD) is the general name for diseases that cause inflammation (swelling and irritation) in the intestines (“gut”). It includes ulcerative proctitis, Crohn’s disease, and ulcerative colitis. How this condition is diagnosed as well as the symptoms and treatments are reviewed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. GI Clinic
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document (4 p.) : digital, PDF file
Subjects (MeSH)
Colitis, Ulcerative
Inflammatory Bowel Diseases
Subjects (LCSH)
Ulcerative colitis
Inflammatory bowel diseases
Abstract
Ulcerative proctitis is a type of inflammatory bowel disease. Inflammatory bowel disease (IBD) is the general name for diseases that cause inflammation (swelling and irritation) in the intestines (“gut”). It includes ulcerative proctitis, Crohn’s disease, and ulcerative colitis. How this condition is diagnosed as well as the symptoms and treatments are reviewed.
Responsibility
Prepared by: GI Clinic
Pamphlet Number
1422
Less detail

9 records – page 1 of 1.